Teva Pharmaceutical Industries (TEVA) EBITDA margin US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
EBITDA margin, % ? 19.0% 27.7% 28.5% 27.5% 26.9%   25.2%  
Changes by years, y/y, % +2pp +9pp +1pp -1pp -1pp     +9.9%

Teva Pharmaceutical Industries. EBITDA margin, %

Teva Pharmaceutical Industries. EBITDA margin, changes, pp

Teva Pharmaceutical Industries (TEVA) EBITDA margin US GAAP (quarter values)

2023Q2 2023Q3 2023Q4 2023Q4 2024Q1   LTM ?
EBITDA margin, % ? 25.2% 27.1% 16.9% 32.6% 24.2%   25.2%
Changes by years, y/y, % -3pp 0pp -10pp +6pp +2pp    
Changes by quarters, q/q, % +3pp +2pp -10pp +16pp -8pp    

Teva Pharmaceutical Industries. EBITDA margin, %

Teva Pharmaceutical Industries. EBITDA margin, changes, pp

Teva Pharmaceutical Industries. EBITDA margin, changes, pp